Healthcare
•3739 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3739)
| Company | Market Cap | Price |
|---|---|---|
|
TAK
Takeda Pharmaceutical Company Limited
Takeda is a large-cap pharmaceutical company with a diversified, high-revenue drug portfolio and pipeline.
|
$56.92B |
$18.22
|
|
ZTS
Zoetis Inc.
Zoetis markets vaccines for companion animals and livestock, a major revenue and product category.
|
$55.51B |
$125.30
-0.52%
|
|
AME
AMETEK, Inc.
Paragon Medical alignment indicates AMETEK provides Medical Device Components as part of its Electromechanical Group.
|
$54.04B |
$230.53
-1.80%
|
|
CAH
Cardinal Health, Inc.
Nuclear medicine radiopharmaceuticals distribution and related imaging agents.
|
$53.03B |
$218.01
-2.32%
|
|
IDXX
IDEXX Laboratories, Inc.
IDEXX manufactures in-clinic diagnostic instruments and related software (e.g., VetLab analyzers, Catalyst) and provides point-of-care diagnostics.
|
$51.80B |
$633.17
-2.39%
|
|
EW
Edwards Lifesciences Corporation
Core product category including SAPIEN/TAVR, Pascal, Evoque, and SAPIEN M3 used in structural heart interventions.
|
$49.43B |
$84.05
-1.37%
|
|
BDX
Becton, Dickinson and Company
BD is a global medical devices & biometrics company with multiple device-based offerings and biometric sensing capabilities.
|
$48.95B |
$171.47
-0.01%
|
|
MET
MetLife, Inc.
Disability Insurance is part of MetLife's product suite within employee benefits.
|
$48.31B |
$73.33
+0.90%
|
|
HLN
Haleon plc
Panadol and other analgesics position Haleon in OTC Pain Relief & Analgesics.
|
$47.81B |
$10.22
-2.34%
|
|
ARGX
argenx SE
argenx's core offerings are monoclonal antibody therapeutics, including VYVGART.
|
$45.75B |
$749.42
+0.09%
|
|
ALNY
Alnylam Pharmaceuticals, Inc.
Alnylam's core product modality is RNA interference (RNAi) therapeutics, including approved products AMVUTTRA, ONPATTRO, GIVLAARI, and OXLUMO.
|
$43.24B |
$326.98
+2.61%
|
|
ALC
Alcon Inc.
Alcon directly designs and manufactures ophthalmology devices including intraocular lenses and surgical platforms.
|
$41.39B |
$84.25
-0.02%
|
|
BBD
Banco Bradesco S.A.
Health insurance products within Bradesco's Insurance Group.
|
$41.36B |
$3.90
+2.46%
|
|
PUK
Prudential plc
Health insurance offerings are a central pillar of Prudential's business strategy and geographic footprint.
|
$41.19B |
$29.98
+0.20%
|
|
VTR
Ventas, Inc.
Healthcare Services & Facilities captures ownership/operation of healthcare facilities including senior housing and outpatient spaces.
|
$40.75B |
$85.79
-1.11%
|
|
ROP
Roper Technologies, Inc.
Verathon bronchoscopes and other medical devices place Roper squarely in Medical Devices & Biometrics.
|
$38.89B |
$368.95
+2.13%
|
|
RMD
ResMed Inc.
CPAP devices and masks are core ResMed medical devices.
|
$37.81B |
$257.77
-0.49%
|
|
SLF
Sun Life Financial Inc.
Health insurance offerings (including group health solutions and stop-loss) are key to Sun Life's business.
|
$36.58B |
$65.32
-0.27%
|
|
GEHC
GE HealthCare Technologies Inc.
GE HealthCare's core product portfolio centers on medical imaging devices and imaging systems (CT/MR/PET).
|
$36.00B |
$77.40
-2.05%
|
|
KVUE
Kenvue Inc.
Kenvue directly manufactures and sells OTC analgesics (e.g., Tylenol).
|
$34.85B |
$18.00
-1.07%
|
|
PAYX
Paychex, Inc.
Health Insurance; PEO insurance solutions for employees.
|
$34.47B |
$96.53
+0.77%
|
|
A
Agilent Technologies, Inc.
Agilent provides diagnostic instrument platforms used in life sciences and clinical diagnostics.
|
$34.17B |
$119.40
-0.95%
|
|
ONC
BeOne Medicines Ltd.
Core oncology-focused biotech; primary business segment is oncology therapeutics.
|
$33.12B |
$296.92
-0.70%
|
|
INSM
Insmed Incorporated
Brensocatib is an oral small molecule therapeutic targeting DPP1, a core part of Insmed's pipeline.
|
$31.97B |
$147.06
-1.88%
|
|
SHG
Shinhan Financial Group Co., Ltd.
Health insurance is a significant component of SHG's insurance offerings.
|
$30.45B |
$61.97
-3.26%
|
|
IQV
IQVIA Holdings Inc.
IQVIA operates as outsourced drug development and clinical research services akin to a CRO.
|
$30.24B |
$178.10
+0.12%
|
|
DXCM
DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
|
$28.43B |
$72.05
-1.17%
|
|
NTRA
Natera, Inc.
Natera operates diagnostic testing and lab services based on cfDNA analysis.
|
$28.02B |
$203.00
-0.01%
|
Showing page 3 of 38 (3739 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
